Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis

A 24-Week, Randomized, Multicenter, Parallel-Group, Double-Blind, Vehicle-Controlled Study on Pimecrolimus Cream 1% Assessing the Steroid-Sparing Effect in the Long Term Management of Pediatric Patients With Severe Atopic Dermatitis

This study will investigate the steroid sparing effect of pimecrolimus cream 1% in pediatric atopic dermatitis

Inclusion Criteria:

• Outpatients aged 2 to < 18 years with severe AD (score 8 or 9 according to Rajka and Langeland)
• responded to 21 days of treatment with prednicarbate cream 0.25% during screening phase

Exclusion Criteria:

• Patients who had received phototherapy, systemic or topical therapy or systemic corticosteroids shortly prior to study